FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Implant, Cochlear
PMA: P200021
·
Supplement: S013
·
Decision Nov 4, 2022
Classifications
1
FEI Numbers
22
Registration Numbers
22
Basic Information
- Device Name
- Implant, Cochlear
- Trade Name
- Neuro Cochlear Implant System (NCIS)
- PMA Number
- P200021
- Supplement Number
- S013
- Device Class
- FDA Class 3
- Product Code
- MCM
- Generic Name
- Implant, cochlear
- Medical Specialty
- Unknown
- Advisory Committee
- Ear, Nose, Throat
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- November 4, 2022
- Date Received
- May 13, 2022
- Supplement Type
- 135 Review Track For 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Approval for increased temperature control of the brazing process of the implant assembly and adjustments to the in-process control methods for detecting hermeticity of the implant, for the Neuro Zti implant, as per the approval letter.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MCM | Implant, Cochlear | FDA class 3 | Unknown |